LONDON, United Kingdom, June 22, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, announces that Peter Rands, Chief Executive Officer, and Dr. Carol Routledge, Chief Medical and Scientific Officer, will participate in a fireside chat at the H. C. Wainwright 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics, and Beyond, taking place in-person and virtually.
Small Pharma Inc(DMT-X)TSX Venture
Today's Change
Delayed Last Update
After Hours Change
After Hours Last Update
Volume
Small Pharma to Participate in the H.C. Wainwright 1st Annual Mental Health Conference on June 27, 2022
Globe Newswire - Wed Jun 22, 2022
Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.